Return to Listing

1 result(s) for Eloxatin

PI Name Protocol # Title
Daniel Herzig IRB00011161 A Phase II Multicenter Randomized Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation Plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Non-Operative Management

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080